Biktarvy, formally known as bictegravir, represents a potent single-tablet regimen for managing HIV infection. This drug unites three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the HIV's ability to copy within the body, considerably reducing the viral load. For many individuals, Biktarvy